50458-398 : Razadyne 12 mg (Galantamine Hydrobromide 15.379 mg) Oral Tablet
NDC: | 50458-398 |
Labeler: | Janssen Pharmaceuticals, Inc. |
Product Type: | Human Prescription Drug |
Drug Name: | Razadyne |
Dosage Form: | Oral Tablet, Film Coated |
Application #: | NDA021169 |
Rev. Date: |
Appearance:
Markings: | JANSSEN;G;12 |
Shapes: |
Round |
Colors: |
Brown |
Size (mm): | 8 |
Segments: * | 1 |
* Segments = the number of equally sized pieces which the pill can be broken into. In this case, a value of 1 indicates a solid pill with no score lines. |
The above image is provided by the U.S. National Library of Medicine (NLM) and is not part of the official label.
NDC Package Codes:
- 50458-398-60: 60 TABLET, FILM COATED IN 1 BOTTLE (50458‑398‑60)
Active Ingredients:
- Galantamine Hydrobromide
Dosage Strength:
- 12 mg
Inactive Ingredients:
- Silicon Dioxide
- Crospovidone
- Hypromelloses
- Lactose Monohydrate
- Magnesium Stearate
- Cellulose, Microcrystalline
- Talc
- Titanium Dioxide
- Ferric Oxide Red
- D&c Yellow No. 10
- Aluminum Oxide
Pharmaceutical Classes:
- Cholinesterase Inhibitor [EPC]
- Cholinesterase Inhibitors [MoA]
Related Products:
Based on records with the same trade name.- 50458-387 24 Hr Razadyne ER 8 mg Extended Release Capsule by Janssen Pharmaceuticals, Inc.
- 50458-388 24 Hr Razadyne ER 16 mg Extended Release Capsule by Janssen Pharmaceuticals, Inc.
- 50458-389 Razadyne ER 24 mg 24hr Extended Release Capsule by Janssen Pharmaceuticals, Inc.
- 50458-396 Razadyne 4 mg Oral Tablet by Janssen Pharmaceuticals, Inc.
- 50458-397 Razadyne 8 mg Oral Tablet by Janssen Pharmaceuticals, Inc.
- 50458-490 Razadyne 4 mg/ml Oral Solution by Janssen Pharmaceuticals, Inc.
- 21695-184 Razadyne 8 mg/1 Oral Tablet, Film Coated by Rebel Distributors Corp
- 21695-591 Razadyne 12 mg (Galantamine Hydrobromide 15.379 mg) Oral Tablet by Rebel Distributors Corp
NDC QR Code
Scan the QR code below to easily reference this data in the future:< Prev: 50458-397Next: 50458-400 >
Related Discussions:
razadyne IR
40mg tabs...
40mg tabs...
Note: The RxChat NDC Database uses publicly available data from the FDA and the U.S. National Library of Medicine (NLM); The NLM is not responsible for the data presented and does not endorse or recommend this or any other product. While we make every effort to ensure that the information presented is accurate, you should assume that all results are unvalidated. To report any errors or inconsistencies please contact us.